NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
49884-937-67 | 49884-937 | HUMAN PRESCRIPTION DRUG | QUESTRAN | Cholestyramine | POWDER, FOR SUSPENSION | ORAL | 20030724 | N/A | ANDA | ANDA077203 | Endo USA, Inc. | CHOLESTYRAMINE | 4 g/5g | 210 g in 1 CAN (49884-937-67) |
63629-2162-1 | 63629-2162 | HUMAN PRESCRIPTION DRUG | Cholestyramine | cholestyramine | POWDER, FOR SUSPENSION | ORAL | 20050915 | N/A | ANDA | ANDA077203 | Bryant Ranch Prepack | CHOLESTYRAMINE | 4 g/5g | 210 g in 1 CAN (63629-2162-1) |
49884-466-50 | 49884-466 | HUMAN PRESCRIPTION DRUG | Cholestyramine | cholestyramine | POWDER, FOR SUSPENSION | ORAL | 20050915 | N/A | ANDA | ANDA077203 | ENDO USA, Inc. | CHOLESTYRAMINE | 4 g/5g | 210 g in 1 BOTTLE (49884-466-50) |
49884-466-65 | 49884-466 | HUMAN PRESCRIPTION DRUG | Cholestyramine | cholestyramine | POWDER, FOR SUSPENSION | ORAL | 20050915 | N/A | ANDA | ANDA077203 | ENDO USA, Inc. | CHOLESTYRAMINE | 4 g/5g | 60 PACKET in 1 CARTON (49884-466-65) / 5 g in 1 PACKET (49884-466-63) |
49884-466-67 | 49884-466 | HUMAN PRESCRIPTION DRUG | Cholestyramine | cholestyramine | POWDER, FOR SUSPENSION | ORAL | 20050915 | N/A | ANDA | ANDA077203 | ENDO USA, Inc. | CHOLESTYRAMINE | 4 g/5g | 210 g in 1 CAN (49884-466-67) |
72162-1505-2 | 72162-1505 | HUMAN PRESCRIPTION DRUG | Cholestyramine | cholestyramine | POWDER, FOR SUSPENSION | ORAL | 20240315 | N/A | ANDA | ANDA077203 | Bryant Ranch Prepack | CHOLESTYRAMINE | 4 g/5g | 210 g in 1 CAN (72162-1505-2) |